{
    "organizations": [],
    "uuid": "27862a817c69af030a8ee9bf88859e0823fc7dc0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-newron-pharmaceuticals-fy-net-loss/brief-newron-pharmaceuticals-fy-net-loss-narrows-to-eur-5-28-million-idUSFWN1QJ018",
    "ord_in_thread": 0,
    "title": "Newron Pharmaceuticals FY Net Loss Narrows To EUR 5.28 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - NEWRON PHARMACEUTICALS SPA:\n* FY TOTAL REVENUES SUBSTANTIALLY INCREASED TO EUR 13.4 MILLION FROM EUR 6.7 MILLION (2016)\n* FY INCREASED LICENSE INCOME (EUR 10.4 MILLION IN 2017 VERSUS. EUR 3.0 MILLION IN 2016)\n* ‍FY NET LOSS EUR 5.28 MILLION VERSUS NET LOSS EUR 15.24​ MILLION YEAR AGO Source text for Eikon: (Gdynia Newsroom)\n ",
    "published": "2018-03-01T14:08:00.000+02:00",
    "crawled": "2018-03-02T20:17:03.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "newron",
        "pharmaceutical",
        "spa",
        "fy",
        "total",
        "revenue",
        "substantially",
        "increased",
        "eur",
        "million",
        "eur",
        "million",
        "fy",
        "increased",
        "license",
        "income",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "net",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}